Hormonal aspects of epithelial ovarian cancer: Review of epidemiological evidence

Clinical Endocrinology

Volumn 49, Issue 6, 1998, Pages 695-707

  Riman, Tomas ^a,b   Persson, Ingemar ^a   Nilsson, Staffan ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FALUN HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; HORMONAL CARCINOGENESIS; HORMONE SUBSTITUTION; HUMAN; INFERTILITY; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS, PITUITARY; GROWTH SUBSTANCES; HUMANS; HYSTERECTOMY; INFERTILITY; MIDDLE AGED; OVARIAN NEOPLASMS; PREGNANCY; REPRODUCTION; STERILIZATION, TUBAL;

EID: 0032417915     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00577.x     Document Type: Review

References (154)

1. Abdollahi, A., Godwin, A.K., Miller, P.D., Getts, L.A., Schultz, D.C., Taguchi, T., Testa, J.R. & Hamilton, T.C. (1997) Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumours. Oncogene, 14, 1973-1979.
2. Abrahamsson, G., Janson, P.O. & Kullander, S. (1997) Steroid release from two human epithelial ovarian tumors: evidence for an intrinsic production in vitro. Gynecologic Oncology, 64, 99-104.
3. Adami, H.O., Persson, I., Hoover, R., Schairer, C. & Bergkvist, L. (1989) Risk of cancer in women receiving hormone replacement therapy. International Journal of Cancer, 44, 833-839.
4. Adami, H.O., Hsieh, C.C., Lambe, M., Trichopoulos, D., Leon, D., Persson, I., Ekbom, A. & Janson, P.O. (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet, 344, 1250-1254.
5. Albrektsen, G., Heuch, I. & Kvåle, G. (1996) Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes and Control, 7, 421-427.
6. Alvarez-Sanchez, F., Segal, S.J., Brache, V., Adejuwon, C.A., Leon, P. & Faundes, A. (1981) Pituitary-ovarian function after tubal ligation. Fertility and Sterility, 36, 606-609.
7. Annegers, J.F., O'Fallon, W. & Kurland, L.T. (1977) Exogenous oestrogens and ovarian cancer. Lancet, ii, 869-870.
8. Annegers, J.F., Strom, H., Decker, D.G., Dockerly, M.B. & O'Fallon, W.M. (1979) Ovarian cancer. Incidence and case-control study. Cancer, 43, 723-729.
9. Baker, T.R. & Piver, M.S. (1994) Etiology, biology, and epidemiology of ovarian cancer. Seminars of Surgical Oncology, 10, 242-248.
10. Balasch, J. & Barri, P.N. (1993) Follicular stimulation and ovarian cancer. Human Reproduction, 8, 990-996.
11. Bamford, P.N. & Steele, S.J. (1982) Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. British Journal of Obstetrics and Gynaecology, 89, 962-964.
12. Barrett-Connor, E. (1992) Risks and benefits of replacement estrogen. Annual Reviews in Medicine, 43, 239-251.
13. Bauknecht, T., Runge, M., Schwall, M. & Pfleiderer, A. (1988) Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecologic Oncology, 29, 147-157.
14. Beral, V., Fraser, P. & Chilvers, C. (1978) Does pregnancy protect against ovarian cancer? Lancet, ii, 1083-1087.
15. Beral, V., Hannaford, P. & Kay, C. (1988) Oral contraceptive use and malignancies of the genital tract. Lancet, ii, 1331-1335.
16. Berchuck, A., Olt, G.J., Everitt, L., Soisson, A.P., Bast, R.C. & Boyer, C.M. (1990) The role of peptide growth factors in epithelial ovarian cancer. Obstetrics and Gynecology, 75, 255-262.
17. Berchuck, A., Rodriguez, G.C., Kamel, A., Dodge, R.K., Soper, J.T., Clarke-Pearson, D.L. & Bast, R.C. (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. American Journal of Obstetrics and Gynecology, 164, 669-674.
18. Biskind, M.S. & Biskind, G.R. (1944) Development of tumours in the rat ovary after transplantation into the spleen. Proceedings of the Society for Experimental Biology and Medicine, 55, 176-179.
19. Björge, T., Engeland, A., Hansen, W. & Tropé, C.G. (1997) Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. International Journal of Cancer, 71, 780-786.
20. v genotype. Biology of Reproduction, 53, 775-779.
21. Booth, M., Beral, V. & Smith, P. (1989) Risk factors for ovarian cancer: a case-control study. British Journal of Cancer, 60, 592-598.
22. Boyd, J. & Rubin, S.C. (1997) Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecology Oncology, 64, 196-206.
23. Brinton, L., Melton, J., Malkasian, G., Bond, A. & Hoover, R. (1989) Cancer risk after evaluation for infertility. American Journal of Epidemiology, 129, 712-722.
24. Bristow, R.E. & Karlan, B.Y. (1996) Ovulation induction, infertility, and ovarian cancer risk. Fertility and Sterility, 66, 499-507.
25. Byers, T., Marshall, J., Graham, S., Mettlin, C. & Swanson, M. (1983) A case-control study of dietary and nondietary factors in ovarian cancer. Journal of the National Cancer Institute, 71, 681-686.
26. Casagrande, J.T., Pike, M.C., Ross, R.K., Louie, E.W., Roy, S. & Henderson, B.E. (1979) 'Incessant ovulation' and ovarian cancer. Lancet, ii, 170-173.
27. CASH study. Centers for Disease Control Cancer and Steroid Hormone Study (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. New England Journal of Medicine, 316, 650-655.
28. Cattanach, J.F. & Milne, B.J. (1988) Post-tubal sterilization problems correlated with ovarian steroidogenesis. Contraception, 38, 541-550.
29. Chen, M.T., Cook, L.S., Daling, J.R. & Weiss, N.S. (1996) Incomplete pregnancies and risk of ovarian cancer (Washington, United States). Cancer Causes and Control, 7, 415-120.
30. Chen, Y., Wu, P.C., Lang, J.H., Ge, W.J., Hartge, P. & Brinton, L.A. (1992) Risk factors for epithelial ovarian cancer in Beijing, China. International Journal of Epidemiology, 21, 23-29.
31. Cohen, J., Forman, R., Harlap, S., Johannisson, E., Lunenfeld, B., deMouzon, J., Pepperell, R., Tarlatzis, B. & Templeton, A. (1993) IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Human Reproduction, 8, 996-999.
32. Corson, S.L., Levinson, C.J., Batzer, F.R. & Otis, C. (1981) Hormonal levels following sterilization and hysterectomy. Journal of Reproductive Medicine, 26, 363-369.
33. Cramer, D.W., Hutchison, G.B., Welch, W.R., Scully, R.E. & Knapp, R.C. (1982) Factors affecting the association of oral contraceptives and ovarian cancer. New England Journal of Medicine, 307, 1047-1051.
34. Cramer, D.W., Hutchison, G.B., Welch, W.R., Scully, R.E. & Ryan, K.J. (1983) Determinants of ovarian cancer risk. I. Reproductive experiences and family history. Journal of the National Cancer Institute, 71, 711-716.
35. Cramer, D.W., Welch, W.R., Scully, R.E. & Wojciechowski, C.A. (1982) Ovarian cancer and talc: a case-control study. Cancer, 50, 372-376.
36. Cramer, D.W. & Xu, H. (1995) Epidemiologic evidence of uterine growth factors in the pathogenesis of ovarian cancer. Annals of Epidemiology, 5, 310-314.
37. Derby, C.A., Lamont Hume, A., McFarland Barbour, M., McPhillips, J.B., Lasater, R.M. & Carleton, R.A. (1993) Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. American Journal of Epidemiology, 137, 1125-1135.
38. Donnez, J., Wauters, M. & Thomas, K. (1981) Luteal function after tubal sterilization. Obstetrics and Gynecology, 57, 65-68.
39. Doyle, L.L., Barclay, D.L., Duncan, G.W. & Kirton, K.T. (1971) Human luteal function following hysterectomy as assessed by plasma progestin. American Journal of Obstetrics and Gynecology, 110, 92-97.
40. Eeles, R.A., Tan, S., Wiltshaw, E., Fryatt, I., A'Hearn, R.P.A., Shepherd, J.H., Harmer, C.L., Blake, P.R. & Chilvers, C.E.D. (1991) Hormone replacement therapy and survival after surgery for ovarian cancer. British Medical Journal, 302, 259-262.
41. Fathalla, M.F. (1971) Incessant ovulation - a factor in ovarian neoplasia? Lancet, ii, 163.
42. Fishel, S. & Jackson, P. (1989) Follicular stimulation for high tech pregnancies: are we playing it safe? British Medical Journal, 299, 309-311.
43. Ford, D. & Easton, D.F. (1995) The genetics of breast and ovarian cancer. British Journal of Cancer, 72, 805-812.
44. Franceschi, S. (1989) Reproductive factors and cancers of the breast, ovary and endometrium. European Journal of Cancer and Clinical Oncology, 25, 1933-1943.
45. Franceschi, S., La Vecchia, C., Booth, M., Tzonou, A., Negri, E., Parazzini, F., Trichopoulos, D. & Beral, V. (1991) Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. International Journal of Cancer, 49, 57-60.
46. Franceschi, S., La Vecchia, C., Helmrich, S.P., Mangioni, C. & Tognoni, G. (1982) Risk factors for epithelial ovarian cancer in Italy. American Journal of Epidemiology, 115, 714-719.
47. Franceschi, S., La Vecchia, C., Negri, E., Guarner, S., Monella, M. & Conti, E. (1994) Fertility drugs and risk of epithelial ovarian cancer in Italy. Human Reproduction, 9, 1673-1675.
48. Franceschi, S., Parazzini, F., Negri, E., Booth, M., La Vecchia, C., Beral, V., Tzonou, A. & Trichopoulos, D. (1991) Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. International Journal of Cancer, 49, 61-65.
49. Godwin, A.K., Testa, J.R. & Hamilton, T.C. (1993) The biology of ovarian cancer development. Cancer, 71, 530-536.
50. Godwin, A.K., Testa, J.R., Handel, L.M., Liu, Z., Vanderveer, L.A., Tracey, P.A. & Hamilton, T.C. (1992) Journal of the National Cancer Institute, 84, 592-601.
51. Gwinn, M.L., Lee, N.C., Rhodes, P.H., Layde, P.M. & Rubin, G.L. (1990) Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. Journal of Clinical Epidemiology, 43, 559-568.
52. Halme, J., Hammond, M.G., Hulka, J.F., Raj, S.G. & Talbert, L.M. (1984) Retrograde menstruation in patients with endometriosis. Obstetrics and Gynecology, 64, 151-154.
53. Hankinson, S.E., Colditz, G.A., Hunter, D.J., Spencer, T.L., Rosner, B. & Stampfer, M.J. (1992) A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstetrics and Gynecology, 80, 708-714.
54. Hankinson, S.E., Colditz, G.A., Hunter, D.J., Willett, W.C., Stampfer, M.J., Rosner, B., Hennekens, C.H. & Speizer, F.E. (1995) A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer, 76, 284-290.
55. Hankinson, S.E., Hunter, D.J., Colditz, G.A., Willett, W.C., Stampfer, M.J., Rosner, B., Hennekens, C.H. & Speizer, F.E. (1993) Tubal ligation, hysterectomy and risk of ovarian cancer a prospective study. Journal of the American Medical Association, 270, 2813-2818.
56. Hartge, P., Hoover, R., McGowan, L., Lesher, L. & Norris, H.J. (1988) Menopause and ovarian cancer. American Journal of Epidemiology, 127, 990-998.
57. Hartge, P., Schiffman, M.H., Hoover, R., McGowan, L., Lesher, L. & Norris, H.J. (1989) A case-control study of epithelial ovarian cancer. American Journal of Obstetrics and Gynecology, 161, 10-16.
58. Helm, G. & Sjöberg, N.O. (1983) Progesterone levels before and after laparoscopic tubal sterilization using endotherm coagulation. Acta Obstetrica Gynecologica et Scandinavica, 62, 63-66.
59. Helzlsouer, K.J., Alberg, A.J., Gordon, O.B., Longcope, C., Bush, T.L., Hoffman, S.C. & Comstock, G.W. (1995) Serum gonadotropins and steroid hormones and the development of ovarian cancer. Journal of the American Medical Association, 274, 1926-1930.
60. Hildreth, N.G., Nelsey, J.L., Livolsi, V.A., Fischer, D.B., Holford, T.R., Mostow, E.D., Schwartz, P.E. & White, C. (1981) An epidemiologic study of epithelial carcinoma of the ovary. American Journal of Epidemiology, 114, 398-405.
61. Hoover, R., Gray, I.A. & Fraumeni Jr, J.F. (1977) Stilbestrol and the risk of ovarian cancer. Lancet, ii, 533-534.
62. Ilekis, J.V., Connor, J.P., Prins, G.S., Ferrer, K., Niederberger, C. & Scoccia, B. (1997) Expression of epidermal growth factor and androgen receptors in ovarian cancer. Gynecologic Oncology, 66, 250-254.
63. Irwin, K.L., Weiss, N.S., Lee, L.C. & Peterson, H.B. (1991) Tubal sterilization, hysterectomy and the subsequent occurrence of epithelial ovarian cancer. American Journal of Epidemiology, 134, 362-369.
64. Janson, P.O. & Jansson, I. (1977) The acute effect of hysterectomy on ovarian blood flow. American Journal of Obstetrics and Gynecology, 127, 349-352.
65. Jiang, X., Hitchcock, A., Bryan, E.J., Watson, R.H., Englefield, P., Thomas, E.J. & Campbell, I.G. (1996) Microsatellite analysis of endometriosis reveals loss of hetgerozygosity at candidate ovarian tumor suppressor gene loci. Cancer Research, 56, 3534-3539.
66. John, E.M., Whittemore, A.S., Harris, R., Intyre, J. & the Collaborative Ovarian Cancer Group (1993) Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Journal of the National Cancer Institute, 85, 142-147.
67. Joly, D.J., Lilienfeld, A.M., Diamond, E.L. & Bross, I.D. (1974) An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. American Journal of Epidemiology, 99, 190-208.
68. Kammerman, S., Demopoulos, R.I., Raphael, C. & Ross, J. (1981) Gonadotropic hormone binding to human ovarian tumors. Human Pathology, 12, 886-890.
69. Kaufman, D.W., Kelly, J.P., Welch, W.R., Rosenberg, L., Stolley, P.D., Warshauer, E.M., Lewis, J., Woodruff, J. & Shapiro, S. (1989) Noncontraceptive estrogen use and epithelial ovarian cancer. American Journal of Epidemiology, 130, 1142-1151.
70. Koch, M., Jenkins, H. & Gaedke, H. (1988) Risk factors of ovarian cancer of epithelial origin: a case-control study. Cancer Detection and Prevention, 13, 131-136.
71. Kvåle, G., Keuch, I., Nilssen, S. & Beral, V. (1988) Reproductive factors and risk of ovarian cancer: a prospective study. International Journal of Cancer, 42, 246-251.
72. Larsson-Cohn, U., Johansson, E.D.B., Kagedal, B. & Vallentin, L. (1977) Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. British Journal of Obstetrics and Gynaecology, 85, 367-372.
73. La Vecchia, C., Decarli, A., Franceschi, S., Regallo, M. & Tognoni, G. (1984) Age at first birth and the risk of epithelial ovarian cancer. Journal of the National Cancer Institute, 73, 663-666.
74. La Vecchia, C., Franceschi, S. & Decarli, A. (1984) Oral contraceptive use and the risk of epithelial ovarian cancer. British Journal of Cancer, 50, 31-34.
75. La Vecchia, C., Liberati, A. & Franceschi, S. (1982) Noncontraceptive estrogen use and the occurrence of ovarian cancer. Journal of the National Cancer Institute, 69, 1207.
76. Lesher, L., McGowan, L., Hartge, P. & Hoover, R. (1985) Age at first birth and risk of epithelial ovarian cancer. Journal of the National Cancer Institute, 74, 1361-1362.
77. Liang, A.O., Greenspan Levenson, A., Layde, P.M., Shelton, J.D., Hatcher, R.A., Potts, M. & Michelson, M.J. (1983) Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. Journal of the American Medical Association, 249, 2909-2912.
78. Lund, E. (1992) Mortality from ovarian cancer among women with many children. International Journal of Epidemiology, 21, 872-876.
79. Malik, S. & Balkwill, F. (1991) Epithelial ovarian cancer: a cytokine propelled disease? British Journal of Cancer, 64, 617-620.
80. McGowan, L., Parent, L., Lednar, W. & Norris, H.J. (1979) The women at risk for developing ovarian cancer. Gynecology Oncology, 7, 325-344.
81. McGowan, L., Norris, H.J., Hartge, P., Hoover, R. & Lesher, L. (1988) Risk factors in ovarian cancer. European Journal of Gynaecologic Oncology, 9, 195-198.
82. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P.K., Norris, F.H., Helvering, L., Morrison, P.K., Rosteck, P., Lai, M., Barrett, J.C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. & Skolnick, M.H. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
83. Miller, A.B., Barclay, T.H.C., Choi, N.W., Grace, M.G., Wall, C., Plante, M., Howe, G.R., Cinader, B. & Davis, F.G. (1980) A study of cancer, parity and age at first pregnancy. Journal of Chronic Diseases, 33, 595-605.
84. Miracle-McMahill, H.L., Calle, E.E., Kosinski, A.S., Rodriguez, C., Wingo, P.A., Thun, M.J. & Heath Jr, C.W. (1997) Tubal ligation and fatal ovarian cancer in a large prospective cohort study. American Journal of Epidemiology, 145, 349-357.
85. Mori, M., Harabuchi, I., Miyake, H., Casagrande, J.T., Henderson, B.E. & Ross, R.K. (1988) Reproductive, genetic, and dietary risk factors for ovarian cancer. American Journal of Epidemiology, 128, 771-777.
86. Mosgaard, B.J., Lidegaard, Ö., Kruger Kjaer, S., Schou, G. & Nyboe Andersen, A. (1997) Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertility and Sterility, 67, 1005-1012.
87. Narod, S.A., Feunteun, J., Lynch, H.T., Watson, P., Conway, T., Lynch, J. & Lenoir, G.M. (1991) Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet, 338, 82-83.
88. Narod, S.A., Goldgar, D., Cannon-Albright, L., Weber, B., Moslehi, R., Ives, E., Lenoir, S. & Lynch, H. (1995) Risk modifiers in carriers of BRCA1 mutations. International Journal of Cancer, 64, 394-398.
89. Narod, S.A., Madlensky, L., Bradley, L., Cole, D., Tonin, P., Rosen, B. & Risch, H.A. (1994) Hereditary and familial ovarian cancer in Southern Ontario. Cancer, 74, 2341-2346.
90. Nasca, P.C., Greenwald, P., Chorost, S., Richart, R. & Caputo, T. (1984) An epidemiologic case-control study of ovarian cancer and reproductive factors. American Journal of Epidemiology, 119, 705-713.
91. Nash, J., Hall, L., Ozols, R., Young, R., Smyth, J. & Hamilton, T.C. (1989) Estrogenic regulation and growth factor expression in human ovarian cancer in vitro (abstract). Proceedings of the American Association for Cancer Research, 30, 1189.
92. Nash, J., Ozols, R., Smyth, J. & Hamilton, T.C. (1989) Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstetrics and Gynecology, 73, 1009-1016.
93. Negri, E., Franceschi, S., La Vecchia, C. & Parazzini, F. (1992) Incomplete pregnancies and ovarian cancer risk. Gynecology Oncology, 47, 234-238.
94. Negri, E., Franceschi, S., Tzonou, A., Booth, M., La Vecchia, C., Parazzini, F., Beral, V., Boyle, P. & Trichopoulos, D. (1991) Pooled analysis of 3 European case-control studies. I. Reproductive factors and risk of epithelial ovarian cancer. International Journal of Cancer, 49, 50-56.
95. Newhouse, M.L., Pearson, R.M., Fullerton, J.M., Boesen, E.A.M. & Shannon, H.S. (1977) A case-control study of carcinoma of the ovary. British Journal of Preventive and Social Medicine, 31, 148-153.
96. Parazzini, F., La Vecchia, C., Negri, E., Bocciolone, L., Fedele, L. & Franceschi, S. (1991) Oral contraceptive use and the risk of ovarian cancer: an Italian case-control study. European Journal of Cancer, 27, 594-598.
97. Parazzini, F., La Vecchia, C., Negri, E. & Gentile, A. (1989) Menstrual factors and the risk of epithelial ovarian cancer. Journal of Clinical Epidemiology, 42, 443-448.
98. Parazzini, F., La Vecchia, C., Negri, E. & Villa, A. (1994) Estrogen replacement therapy and ovarian cancer risk. International Journal of Cancer, 57, 135-136.
99. Parazzini, F., Negri, E., La Vecchia, C., Luchini, L. & Mezzopane, R. (1993) Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstetrics and Gynecology, 81, 363-366.
100. Parkin, D.M., Pisani, P. & Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer, 54, 594-606.
101. Persson, I., Adami, H.O., Bergkvist, L., Lindgren, A., Pettersson, B., Hoover, R. & Schairer, C. (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. British Medical Journal, 298, 147-151.
102. Pisani, P., Parkin, D.M. & Ferlay, J. (1983) Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer, 54, 891-903.
103. Polychronopoulou, A., Tzonou, A., Hsieh, C.C., Kaprinis, G., Rebelakos, A., Toupadaki, N. & Trichopoulos, D. (1993) Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. International Journal of Cancer, 55, 402-407.
104. Purdie, D., Green, A., Bain, C., Siskind, V., Ward, B., Hacker, N., Quinn, M., Wright, G., Russell, P., Susil, B. & Survey of Women's Health Study Group (1995) Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. International Journal of Cancer, 62, 678-684.
105. Radwanska, E., Headly, S.K. & Dmowski, P. (1982) Evaluation of ovarian function after tubal sterilization. Journal of Reproductive Medicine, 27, 376-384.
106. Rajaniemi, H., Kauppila, A., Rönnberg, L., Selander, K. & Pystynen, P. (1981) LH(hCG) receptor in benign and malignant tumor of human ovary. Acta Obstetrica et Gynecologica Scandinavica Supplement, 101, 83-86.
107. Rao, R.B. & Slotman, B.J. (1991) Endocrine factors in common epithelial ovarian cancer. Endocrine Reviews, 12, 14-26.
108. Ridderheim, M., Mählck, C.G., Selstam, G., Stendahl, U. & Bäckström, T. (1993) Steroid production in different parts of malignant and benign ovarian tumors in vitro. Cancer Research, 53, 2309-2312.
109. Risch, H.A. (1996) Estrogen replacement therapy and risk of epithelial ovarian cancer. Gynecologic Oncology, 63, 254-257.
110. Risch, H.A., Marrett, L.D. & Howe, G.R. (1994) Parity, contraception, infertility, and the risk of epithelial ovarian cancer. American Journal of Epidemiology, 140, 585-597.
111. Risch, H.A., Marrett, L.D., Jain, M. & Howe, G.R. (1996) Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. American Journal of Epidemiology, 144, 363-372.
112. Rodriguez, C.G., Berchuck, A., Whitaker, R.S., Schlossman, D., Clarke-Pearson, D.L. & Bast Jr, R.C. (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. American Journal of Obstetrics and Gynecology, 164, 745-750.
113. Rodriguez, C., Calle, E.E., Coates, R.J., Miracle-McMahill, H.L., Thun, M.J. & Heath Jr, C.W. (1995) Estrogen replacement therapy and fatal ovarian cancer. American Journal of Epidemiology, 141, 828-835.
114. Ron, E., Lunenfeld, B., Menczer, J., Blumstein, T., Katz, L., Oelsner, G. & Serr, D. (1987) Cancer incidence in a cohort of infertile women. American Journal of Epidemiology, 125, 780-790.
115. Rosenberg, L., Palmer, J.R., Zauber, A.C., Warshauer, M.E., Lewis Jr, J.L., Strom, B.L., Harlap, S. & Shapiro, S. (1994) A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. American Journal of Epidemiology, 139, 654-661.
116. Rosenberg, L., Shapiro, S., Slone, D., Kaufman, D.W., Helmrich, S.P., Miettinen, O.S., Stolley, P.D., Rosenshein, N.B., Schottenfeld, D. & Engle, R.L. (1982) Epithelian ovarian cancer and combination oral contraceptives. Journal of the American Medical Association, 247, 3210-3212.
117. Rosenblatt, K.A., Thomas, D.B., Noonan, E.A. & the WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1992) High dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. European Journal of Cancer, 28A, 1872-1876.
118. Rosenblatt, K.A., Thomas, D.B. & the WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1993) Lactation and the risk of epithelial ovarian cancer. International Journal of Epidemiology, 22, 192-197.
119. Rosenblatt, K.A., Thomas, D.B. & the WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1996) Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. Cancer Epidemiology, Biomarkers & Prevention, 5, 933-935.
120. Rossing, M.A., Daling, J.R., Weis, N.S., Moore, D.E. & Self, S.G. (1994) Ovarian tumors in a cohort of infertile women. New England Journal of Medicine, 331, 771-776.
121. Schildkraut, J.M., Bastos, E. & Berchuck, A. (1997) Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. Journal of the National Cancer Institute, 89, 932-938.
122. Schildkraut, J.M., Schwingl, P.J., Bastos, E., Evanoff, A. & Hughes, C. (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstetrics and Gynecology, 88, 554-559.
123. Schneider, A.P. (1987) Risk factor for ovarian cancer. New England Journal of Medicine, 317, 508-509.
124. Shapiro, S. (1995) Risk of ovarian cancer after treatment for infertility: letter, comment. New England Journal of Medicine, 332, 1301.
125. Shu, X.O., Brinton, L.A., Gao, Y.T. & Yuan, J.M. (1989) Population-base case-control study of ovarian cancer in Shanghai. Cancer Research, 49, 3670-3674.
126. Shushan, A., Paltiel, O., Iscovich, J., Elchalal, U., Peretz, T. & Schenker, J.G. (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertility Sterility, 65, 13-18.
127. Simon, W.E., Albrecht, M., Hänsel, M., Dietel, M. & Hölzel, F. (1983) Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. Journal of the National Cancer Institute, 70, 839-845.
128. Slotman, B.J. & Rao, B.R. (1988) Ovarian cancer (review). Anticancer Research, 8, 417-434.
129. Smith, E.M., Sowers, M.F. & Burns, T.L. (1984) Effects of smoking on the development of female reproductive cancer. Journal of the National Cancer Institute, 73, 371-376.
130. Spirtas, R., Kaufman, S.C. & Alexander, N.J. (1993) Fertility drugs and ovarian cancer: red alert or red herring? Fertility and Sterility, 59, 291-293.
131. Stadel, B.V. (1975) The etiology and prevention of ovarian cancer. American Journal of Obstetrics and Gynecology, 123, 772-774.
132. Stanford, J.L. (1991) Oral contraceptives and neoplasia of the ovary. Contraception, 43, 543-556.
133. Stouffer, F.L., Grodin, M.S., Davis, J.R. & Surwit, E.A. (1984) Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. Journal of Clinical Endocrinology and Metabolism, 59, 441-446.
134. Szamborski, J., Czerwinski, W., Gadomska, H., Kowalski, M. & Wacker-Pujdak, B. (1981) Case control study of high-risk factors in ovarian carcinomas. Gynecology Oncology, 11, 8-16.
135. Sörensen, T., Ladehoff, P., Lindholm, P. & Qvist, K. (1981) Follicular stimuating hormone, luteinizing hormone and estrogen levels before and after female sterilization. Acta Obstetrica et Gynecologica Scandinavica, 60, 559-561.
136. Tavani, A., Negri, E., Franceschi, S., Parazzini, F. & La Vecchia, C. (1993) Risk factors for epithelial ovarian cancer in women under age 45. European Journal of Cancer, 29A, 1297-1301.
137. Topo, P., Klaukka, T., Hemminki, E. & Uutela, A. (1991) Use of hormone replacement therapy in 1976-1989 by 45-64 year old Finnish women. Journal of Epidemiology and Community Health, 45, 277-280.
138. Tzonou, A., Day, N.E., Trichopoulous, D., Walker, A., Saliaraki, M., Papapostolou, M. & Polychronopoulou, A. (1984) The epidemiology of ovarian cancer in Greece: a case-control study. European Journal of Cancer and Clinical Oncology, 20, 1045-1052.
139. Venn, A., Watson, L., Lumley, J., Giles, G., King, C. & Healy, D. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet, 346, 995-1000).
140. Vessey, M., Metcalfe, A., Wells, C., McPherson, K., Westhoff, C. & Yeates, D. (1987) Ovarian neoplasms, functional ovarian cysts, and oral contraceptives. British Medical Journal, 294, 1518-1520.
141. Vessey, M.P. & Painter, R. (1995) Endometrial and ovarian cancer and oral contraceptives - findings in a large cohort study. British Journal of Cancer, 71, 1340-1342.
142. Voigt, L.F., Harlow, B.L. & Weiss, N.S. (1986) The influence of age at first birthy and parity on ovarian cancer risk. American Journal of Epidemiology, 124, 490-491.
143. Voigt, L.F., Weiss, N.S., Chu, J., Daling, J.R., McKnight, B. & Van Belle, G. (1991) Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet, 338, 274-277.
144. Weiss, N.S. & Harlow, B.L. (1986) Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer. American Journal of Epidemiology, 124, 856-858.
145. Weiss, N.S., Lyon, J.L., Krishnamurthy, S., Dietert, S.E., Liff, J.M. & Daling, J.R. (1982) Noncontraceptive estrogen use and the occurrence of ovarian cancer. Journal of the National Cancer Institute, 68, 95-98.
146. Weiss, N.S., Lyon, J.L., Liff, J.M., Vollmer, W.M. & Daling, J.R. (1981) Incidence of ovarian cancer in relation to the use of oral contraceptives. International Journal of Cancer, 28, 669-671.
147. West, R.O. (1966) Epidemiologic study of malignancies of the ovaries. Cancer, 19, 1001-1007.
148. Whittemore, A.S., Harris, R., Itnyre, J. & the Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. American Journal of Epidemiology, 136, 1184-1203.
149. Whittemore, A.S., Wu, M.L., Paffenbarger, R.S., Sarles, D.L., Kampert, J.B., Grosser, S., Jung, D.L., Ballon, S., Hendrickson, M. & Mohle-Boetani, J. (1989) Epithelial ovarian cancer and the ability to conceive. Cancer Research, 49, 4047-4052.
150. WHO Collaborative Study of Neoplasia and Steroid Contraceptives (1989) Epithelial ovarian cancer and combined oral contraceptives. International Journal of Epidemiology, 18, 538-545.
151. Willett, W.C., Bain, C., Hennekens, C.H., Rosner, B. & Speizer, F.E. (1981) Oral contraceptives and risk of ovarian cancer. Cancer, 48, 1684-1687.
152. Wu, M.L., Whittemore, A.S., Paffenberger Jr, R.S., Sarles, D.L., Kampert, J.B., Grosser, S., Jung, D.L., Ballon, S., Hendrickson, M. & Mohle-Boetani, J. (1988) Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. American Journal of Epidemiology, 128, 1216-1227.
153. Wynder, E.L., Dodo, H. & Barber, H.R.K. (1969) Epidemiology of cancer of the ovary. Cancer, 23, 352-370.
154. Ziehl, H.K. (1982) Estrogen's role in endometrial cancer. Obstetrics and Gynecology, 60, 509-515.